pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 15·1 min read
save

Scientists and stakeholders overwhelmingly oppose White House grantmaking overhaul, analysis finds

Jul 15, 2026·read at STAT ↗RegulatoryNegative

Researchers at the University of North Carolina at Chapel Hill, working with STAT, examined a flood of public comments on a White House proposal to revamp the federal "Uniform Guidance" that governs contracts and grants.

The analysis, which used a large language model to sort comments as supportive or opposed, found that roughly 95 % of the 496,769 comments were against the changes, while only about 1 % expressed support. Of the comments posted in full (52,322), the opposition was overwhelming.

Around 60 % of the dissenting comments cited worries that the new rules could increase political control over grant funding. The proposal would represent a fundamental shift in how federal research money is allocated.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Flood of comments on White House grantmaking overhaul is largely negative, analysis shows”

read at STAT ↗
2,062 words · retrieved Jul 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
TORRENTUNIQUE
drugs
nicotinenicotine ER

related stories

  • Sep 15Opinion: 3 lessons from the tobacco settlement on how states should use money from MetaSTAT
  • Sep 8An administrative gap delays access to new pancreatic cancer treatmentSTAT
  • Sep 8Reynolds is selling fruity new vapes unauthorized by FDASTAT
  • Aug 28Juul gets OK to sell updated vaping device with age-gating technologySTAT
  • Aug 12Vaping and cannabis hit record highs among young adults in 2025: SurveySTAT